NIH Foundation, Biomarkers Consortium Team on Cancer Trials | GenomeWeb

This article has been updated with comments from a press conference.

By Matt Jones

NEW YORK (GenomeWeb News) – Government and university scientists in the US and drug development companies will undertake a new personalized clinical trial model that will use genetic biomarkers from individual tumors to screen several new drugs for breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.